Rosetta Genomics Ltd. announced the appointment of Maria Fe Paz, M.D. Ph.D., effective immediately, as a medical affairs consultant in the role of Interim Chief Medical Officer, with plans to transition her to Chief Medical Officer of Rosetta Genomics upon receipt of a valid work visa that supports her planned relocation to the U.S. Dr. Paz is an accomplished chief medical officer with nearly 15 years' of experience in the pharmaceutical and biomedical industry, with demonstrated achievements in molecular diagnostics, translational and precision medicine. Dr. Paz joins Rosetta Genomics from Labceutics and the Diaceutics Group, where she was the Founder-President and Chief Medical Officer, respectively. Dr. Paz will be providing her services as a consultant through a third party corporation, until she is granted a valid U.S. work visa.